Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | orlistat | 3034010 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | orlistat | 3034010 | drug-path |
| Proteasome | R-HSA-68819 | map03050 | orlistat | 3034010 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | fluorocurarine | 21586665 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | fluorocurarine | 21586665 | drug-path |
| ECM-receptor interaction | R-HSA-373711 | map04512 | fluorocurarine | 21586665 | drug-path |
| Glioma | Q9NZM4 | map05214 | moxonidine | 4810 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | moxonidine | 4810 | drug-path |
| Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | moxonidine | 4810 | drug-path |
| Pathways in cancer | R-HSA-9824443 | map05200 | moxonidine | 4810 | drug-path |
| Shigellosis | 0 | map05131 | moxonidine | 4810 | drug-path |
| Pathogenic Escherichia coli infection | R-HSA-9609646 | map05130 | moxonidine | 4810 | drug-path |
| Pancreatic cancer | R-HSA-9700206 | map05212 | moxonidine | 4810 | drug-path |
| Prostate cancer | R-HSA-2990872 | map05215 | moxonidine | 4810 | drug-path |
| Tight junction | R-HSA-2134514 | map04530 | moxonidine | 4810 | drug-path |
| Fc epsilon RI signaling pathway | R-HSA-2454202 | map04664 | moxonidine | 4810 | drug-path |
| VEGF signaling pathway | R-HSA-194138 | map04370 | moxonidine | 4810 | drug-path |
| Melanoma | Q9UHD0-PRO_0000015379 | map05218 | moxonidine | 4810 | drug-path |
| TGF-beta signaling pathway | R-HSA-168638 | map04350 | moxonidine | 4810 | drug-path |
| Jak-STAT signaling pathway | R-HSA-168638 | map04630 | moxonidine | 4810 | drug-path |